LIU SHEN & ASSOCIATES

XU,Feifei

Partner | Patent Attorney | Attorney at Law

TECHNICAL FIELD:

Organic Chemistry , Bio & Pharmaceutical , Chemical Engineering

TEL: 86-10-6268 1616

FAX: 86-10-6268 1818

EMAIL: ffxu@liu-shen.com

PERSONAL SUMMARY:

EDUCATION

Peking University, Chemical Biology, Master (2006-2008)

Peking University, Pharmacy, Bachelor (2002-2006)


QUALIFICATIONS

Legal Professional Qualification of PRC

Member of the PRC Patent Bar


PROFESSIONAL EXPERIENCE

Ms. Xu has focused her practice on providing whole-process patent portfolio management and patent enforcement.  She has assisted several world-renowned companies in handling patent applications in China, and provided advice to domestic and foreign companies in patent prosecution and patent enforcement. Ms. Xu also is also experienced in patent due diligence, analysis and legal opinions, and patent invalidation proceedings. Recently, she has participated in the legal affairs of intellectual property in investment and financing of small and medium-sized start-up companies, and investment institutions. Ms. Xu's technical fields include pharmacy, biology, agriculture, personal care products and polymer materials.


HIGHLIGHTS:

Dispute resolution

-     Representing a multinational pharmaceutical company, participated in one of its compound patent invalidation proceedings (2020)

-     Representing a multinational pharmaceutical company, participated in one of its crystal patent invalidation proceedings (2020)

-     Participated in a patent invalidation proceedings of a European pharmaceutical company (2021)

Legal consulting

-     Providing patent due diligence service and drafted legal opinions for a financing project of a Shanghai based pharmaceutical company (2020)

-     Providing due diligence service for an investment company to invest in a drug R&D company in Shanghai (2020)

-     Providing patent due diligence service for a Beijing based pharmaceutical company's listing project in Hong Kong (2020)

-     Providing patentability analysis of a formulation patent for a multinational pharmaceutical company (2020)


WORKING LANGUAGE:

Chinese,English

MEMBERSHIP: